- Market Capitalization, $K 2,035,805
- Shares Outstanding, K 395,302
- Annual Sales, $ 614,060 K
- Annual Income, $ -18,000 K
- 60-Month Beta 2.23
- Price/Sales 3.33
- Price/Cash Flow N/A
- Price/Book 3.24
|Period||Period Low||Period High||Performance|
| || |
-0.46 (-8.20%)since 08/17/21
| || |
+0.22 (+4.46%)since 06/17/21
| || |
+0.95 (+22.62%)since 09/17/20
The stock market is on a winning streak, with the benchmark S&P 500 index recording fresh highs for seven straight months. Given surging investor confidence and strong economic recovery, we think fundamentally...
Investors in Amarin Corp plc saw new options begin trading today, for the October 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the...
VASCEPA found in prespecified and post hoc analyses to reduce first and total primary endpoints by 26% and 35%, respectively, in patients with prior Myocardial Infarction
Amarin Corporation plc (NASDAQ:AMRN) today announced that new data that add to the growing body of knowledge on VASCEPA(R)/VAZKEPA (icosapent ethyl) in patients at risk for major adverse cardiovascular...
Amarin's (AMRN) Vascepa sales benefit from increased demand in the United States during the second quarter. The drug retains majority market share in its segment amid rising generic competition. Stock...
Amarin's (AMRN) second-quarter results are likely to reflect recovery in Vascepa sales amid potential recovery in COVID-19 related disruptions.
Investors in Amarin Corp plc saw new options begin trading today, for the September 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for...
Investors in Amarin Corp plc saw new options become available this week, for the March 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time...
Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter and six month 2021 financial results...